Evaxion Biotech Stock (NASDAQ: EVAX) stock price, news, charts, stock research, profile.
|Vol / Avg.43.518K / 146.534K||Mkt Cap22.888M|
|Day Range0.772 - 0.820||52 Wk Range0.470 - 2.440|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-03-31||Lake Street||Thomas Flaten||Maintains||Buy||Lowers||18.00||7.00|
|2021-03-02||Oppenheimer||Kevin DeGeeter||Initiates Coverage On||Outperform||Announces||-||18.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Evaxion Biotech (NASDAQ: EVAX) through any online brokerage.
The latest price target for Evaxion Biotech (NASDAQ: EVAX) was reported by Lake Street on Friday, March 31, 2023. The analyst firm set a price target for 7.00 expecting EVAX to rise to within 12 months (a possible 753.87% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Evaxion Biotech (NASDAQ: EVAX) is $0.8198 last updated December 1, 2023 at 9:02 PM UTC.
There is no dividend information for Evaxion Biotech.
Evaxion Biotech’s Q3 earnings are confirmed for Friday, December 15, 2023.
There is no upcoming split for Evaxion Biotech.
Evaxion Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.